<DOC>
	<DOCNO>NCT02355171</DOCNO>
	<brief_summary>The 'Personalize My treatment ' ( PMT ) platform novel form biobanking cancer patient willingly consent provide residual , clinical sample ( surplus diagnostic testing ) tumor cancer research , give access medical record data collection follow prospectively throughout trajectory illness . They willingly consent recontacted informed research project , include clinical trial .</brief_summary>
	<brief_title>Personalize Treatment</brief_title>
	<detailed_description />
	<criteria>Cancer patient 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>